3.515
price down icon8.94%   -0.345
 
loading
Schlusskurs vom Vortag:
$3.86
Offen:
$3.75
24-Stunden-Volumen:
2.23M
Relative Volume:
0.27
Marktkapitalisierung:
$1.05B
Einnahmen:
$6.23M
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-9.0128
EPS:
-0.39
Netto-Cashflow:
$-68.47M
1W Leistung:
-7.50%
1M Leistung:
-11.68%
6M Leistung:
+105.56%
1J Leistung:
+280.58%
1-Tages-Spanne:
Value
$3.51
$3.76
1-Wochen-Bereich:
Value
$3.51
$4.00
52-Wochen-Spanne:
Value
$0.6513
$5.225

Precigen Inc Stock (PGEN) Company Profile

Name
Firmenname
Precigen Inc
Name
Telefon
301-556-9900
Name
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Mitarbeiter
25
Name
Twitter
@precigen
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
PGEN's Discussions on Twitter

Vergleichen Sie PGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PGEN
Precigen Inc
3.515 1.36B 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
378.38 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.78 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.08 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
710.03 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.88 36.23B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-15 Hochstufung JP Morgan Underweight → Neutral
2024-03-22 Herabstufung JP Morgan Neutral → Underweight
2023-05-23 Eingeleitet JP Morgan Neutral
2022-11-18 Eingeleitet Cantor Fitzgerald Overweight
2021-02-25 Eingeleitet Stifel Buy
2021-02-22 Eingeleitet Wells Fargo Overweight
2021-02-18 Eingeleitet B. Riley Securities Buy
2020-05-08 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Precigen Inc Aktie (PGEN) Neueste Nachrichten

pulisher
01:41 AM

Precigen (NASDAQ:PGEN) Trading Down 6.1%Time to Sell? - MarketBeat

01:41 AM
pulisher
Sep 23, 2025

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization - Yahoo Finance

Sep 23, 2025
pulisher
Sep 23, 2025

The Outlook For Precigen (NASDAQ:PGEN) - Seeking Alpha

Sep 23, 2025
pulisher
Sep 23, 2025

Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 3,596,892 Shares of Stock - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen (PGEN) Is Up 7.2% After Securing $125M Credit For PAPZIMEOS Commercialization Plans Has The Bull Case Changed? - simplywall.st

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen (NASDAQ:PGEN) Director Randal J. Kirk Sells 1,403,360 Shares - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near? - Yahoo Finance

Sep 23, 2025
pulisher
Sep 22, 2025

Precigen Bets On Gene Therapies After First FDA Approval - Finimize

Sep 22, 2025
pulisher
Sep 21, 2025

Precigen (NASDAQ:PGEN) Stock Price Up 5.2%Time to Buy? - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Death Cross: How does Coherent Corp correlate with NasdaqJuly 2025 Breakouts & Real-Time Volume Spike Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Inspire Investing LLC Makes New Investment in Precigen, Inc. $PGEN - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Growth Review: What are Precigen Incs growth levers2025 EndofYear Setup & Growth Focused Investment Plans - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization - Yahoo Finance

Sep 20, 2025
pulisher
Sep 18, 2025

Investment Review: Can Precigen Inc beat the S P 5002025 EndofYear Setup & Free Community Consensus Stock Picks - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen (NASDAQ:PGEN) Stock Price Down 3.7%What's Next? - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen converts preferred stock into 54.9 million common shares By Investing.com - Investing.com Nigeria

Sep 18, 2025
pulisher
Sep 17, 2025

Precigen Converts Preferred Stock to Common Shares - TipRanks

Sep 17, 2025
pulisher
Sep 17, 2025

Precigen converts preferred stock into 54.9 million common shares - Investing.com India

Sep 17, 2025
pulisher
Sep 17, 2025

Pullback Watch: Can Precigen Inc scale operations efficiently2025 Winners & Losers & Community Verified Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Movement Recap: Is Precigen Inc a play on infrastructure spendingRate Hike & Risk Managed Investment Signals - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Analyst Downgrade: Is Precigen Inc stock a top performer YTDTrade Ideas & Expert Approved Momentum Ideas - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Growth Value: Is Precigen Inc. exposed to political riskJuly 2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Is Precigen Stock Ready For Takeoff? - StocksToTrade

Sep 16, 2025
pulisher
Sep 16, 2025

Resistance Check: Will Precigen Inc stock go up in YEARWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Ideas Watch: Will Precigen Inc stock go up in YEAREarnings Summary Report & Daily Market Momentum Tracking - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Precigen announces up to $125M non-dilutive financing - MSN

Sep 15, 2025
pulisher
Sep 15, 2025

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - Yahoo Finance

Sep 15, 2025
pulisher
Sep 14, 2025

MetLife Investment Management LLC Purchases New Position in Precigen, Inc. $PGEN - MarketBeat

Sep 14, 2025
pulisher
Sep 14, 2025

Precigen Stock Tumbles as Company Undertakes Massive Shares Sale - StocksToTrade

Sep 14, 2025
pulisher
Sep 13, 2025

Could Precigen's (PGEN) New Credit Facility Reshape Its Approach to Shareholder Dilution? - simplywall.st

Sep 13, 2025
pulisher
Sep 12, 2025

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN

Sep 12, 2025
pulisher
Sep 12, 2025

4 years from clinic to approval — Precigen’s ‘unprecedented’ FDA nod and what comes next - PharmaVoice

Sep 12, 2025
pulisher
Sep 12, 2025

EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS - Eastern Progress

Sep 12, 2025

Finanzdaten der Precigen Inc-Aktie (PGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Precigen Inc-Aktie (PGEN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
KIRK RANDAL J
Director
Sep 18 '25
Sale
3.86
1,403,360
5,416,970
12,117,429
$34.92
price down icon 2.39%
$81.44
price down icon 3.18%
$28.68
price down icon 2.58%
$97.88
price down icon 1.88%
$135.83
price down icon 3.62%
biotechnology ONC
$327.37
price down icon 0.64%
Kapitalisierung:     |  Volumen (24h):